Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fukuda Denshi CoTSE:6960 -0.25%83 5-Year Yield-on-Cost % is 2.47 as of Aug. 07, 2026, which is 24% below its 10-year median of 3.24. GuruFocus rates TSE:6960 with a GF Score™ of 83/100 and a GF Value™ of 円7,344.88 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 317 Medical Devices & Instruments companies, Fukuda Denshi Co ranks better than 50.79% on this metric.
Fukuda Denshi Co's yield on cost for the quarter that ended in Mar. 2026 was 2.47.
The historical rank and industry rank for Fukuda Denshi Co's 5-Year Yield-on-Cost % or its related term are showing as below:
TSE:6960'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.05 Med: 3.24 Max: 5.45
Current: 2.47
During the past 13 years, Fukuda Denshi Co's highest Yield on Cost was 5.45. The lowest was 2.05. And the median was 3.24.
TSE:6960's 5-Year Yield-on-Cost % is ranked better than 50.79% of 317
companies
in the Medical Devices & Instruments industry
Industry Median: 2.43
vs TSE:6960: 2.47
Fukuda Denshi Co (TSE:6960) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Fukuda Denshi Co 5-Year Yield-on-Cost % Related Terms
TSE:6960 vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Fukuda Denshi Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fukuda Denshi Co 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fukuda Denshi Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Fukuda Denshi Co's 5-Year Yield-on-Cost % falls into.
Fukuda Denshi Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Fukuda Denshi Co (TSE:6960) has a 5-Year Yield-on-Cost % of 2.47 as of Aug. 07, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Fukuda Denshi Co and its competitors. This is 24% below median its historical median of 3.24. Over the past decade, Fukuda Denshi Co's 5-Year Yield-on-Cost % has ranged from 2.05 to 5.45. According to the industry distribution chart, Fukuda Denshi Co ranks #156 out of 317 companies in the Medical Devices & Instruments industry, placing it in the top 49.2%.
Is Fukuda Denshi Co's 5-Year Yield-on-Cost % too high?
Fukuda Denshi Co's current 5-Year Yield-on-Cost % of 2.47 is 24% below median its 10-year median of 3.24. Over the past 10 years, this metric has ranged from a low of 2.05 to a high of 5.45. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.43. Fukuda Denshi Co's value of 2.47 is 1.6% above this industry median. Based on the distribution chart, Fukuda Denshi Co ranks #156 out of 317 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Fukuda Denshi Co has a GF Score™ of 83/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fukuda Denshi Co's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Fukuda Denshi Co ranks #156 out of 317 companies for 5-Year Yield-on-Cost %. This puts Fukuda Denshi Co in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.43. Fukuda Denshi Co's value of 2.47 is 1.6% above this benchmark. Historically, Fukuda Denshi Co's own 5-Year Yield-on-Cost % has ranged from 2.05 to 5.45 over the past decade. While the company's 10-year median is 3.24 vs. the industry median of 2.43, Fukuda Denshi Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.43, based on 317 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fukuda Denshi Co's current 5-Year Yield-on-Cost % of 2.47 is 1.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Fukuda Denshi Co and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fukuda Denshi Co's current 5-Year Yield-on-Cost % is 2.47, which is 24% below median its own 10-year median of 3.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fukuda Denshi Co stock overvalued right now?
Based on GuruFocus' analysis, Fukuda Denshi Co (TSE:6960) is currently considered Significantly Overvalued. The stock's GF Value™ is 円7,344.88, compared to a current price of 円11,820.00 — trading 60.9% above its estimated fair value. The current 5-Year Yield-on-Cost % is 2.47, which is 24% below median its 10-year median of 3.24 and 1.6% above the Medical Devices & Instruments industry median of 2.43. Fukuda Denshi Co's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Fukuda Denshi Co (TSE:6960), the current 5-Year Yield-on-Cost % is 2.47 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fukuda Denshi Co (TSE:6960) Overvalued in 2026?
Based on GuruFocus' analysis, Fukuda Denshi Co stock appears to be overvalued.
The current stock price of 円11,820.00 is trading 60.9% above its estimated GF Value™ of 円7,344.88.
GuruFocus considers Fukuda Denshi Co to be Significantly Overvalued.
Key valuation signals for TSE:6960:
5-Year Yield-on-Cost %: 2.47 (24% below median its 10-year median of 3.24)
GF Value™: 円7,344.88 vs. price of 円11,820.00 (60.9% above fair value)
Industry Position: 1.6% above the Medical Devices & Instruments median (#156 of 317)
No single metric tells the full story. See the TSE:6960 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.
83GF Score
Get the complete analysis for TSE:6960
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6960 has been successfully added to your 
